FLI1
FLI1 (Friend Leukemia Integration 1) is a gene that encodes a transcription factor involved in the regulation of development and cell proliferation. It is a member of the Ets family of transcription factors and is recognized for its role in Ewing's sarcoma, a rare type of cancer that occurs in bones or in the soft tissue around the bones.
Function[edit]
The FLI1 gene provides instructions for making a protein that plays a crucial role in the development and function of cells that form blood vessels, blood cells, and certain types of connective tissue. This protein is a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of particular genes.
Clinical significance[edit]
Mutations in the FLI1 gene have been associated with Ewing's sarcoma, a rare type of cancer that occurs in bones or in the soft tissue around the bones. This is primarily due to a translocation between chromosomes 11 and 22, which fuses the FLI1 gene with the EWSR1 gene. The resulting EWSR1/FLI1 fusion protein is believed to contribute to the development of Ewing's sarcoma by disrupting normal gene regulation.
FLI1 is also implicated in other diseases. For instance, it is overexpressed in the majority of cases of systemic lupus erythematosus, an autoimmune disease. Moreover, it has been associated with vasculitis, a condition that involves inflammation of the blood vessels.
Research[edit]
Research into the FLI1 gene and its associated protein continues to be a significant focus in the field of genetics. Understanding the precise mechanisms by which FLI1 mutations contribute to disease can potentially lead to the development of targeted therapies for conditions like Ewing's sarcoma and systemic lupus erythematosus.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

